These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33329805)

  • 1. Perioperative management of patients receiving non-vitamin K antagonist oral anticoagulants: up-to-date recommendations.
    Kim KS; Song JW; Soh S; Kwak YL; Shim JK
    Anesth Pain Med (Seoul); 2020 Apr; 15(2):133-142. PubMed ID: 33329805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal agents for non-vitamin K antagonist oral anticoagulants.
    Levy JH; Douketis J; Weitz JI
    Nat Rev Cardiol; 2018 May; 15(5):273-281. PubMed ID: 29345686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEMATURIA AND OTHER KINDS OF BLEEDINGS ON NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: AN UPDATED OVERVIEW ON OCCURRENCE, PATHOMECHANISMS AND MANAGEMENT.
    Wojtowicz D; Tomaszuk-Kazberuk A; Małyszko J; Koziński M
    Wiad Lek; 2020; 73(11):2528-2534. PubMed ID: 33454696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who, when, and how to reverse non-vitamin K oral anticoagulants.
    Aronis KN; Hylek EM
    J Thromb Thrombolysis; 2016 Feb; 41(2):253-72. PubMed ID: 26627486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of bleeding in patients receiving non-vitamin K antagonists.
    Balla S; Koerber S; Flaker G
    Postgrad Med J; 2017 Apr; 93(1098):221-225. PubMed ID: 27986971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal.
    Brown KS; Zahir H; Grosso MA; Lanz HJ; Mercuri MF; Levy JH
    Crit Care; 2016 Sep; 20(1):273. PubMed ID: 27659071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants.
    Mujer MTP; Rai MP; Atti V; Dimaandal IL; Chan AS; Shrotriya S; Gundabolu K; Dhakal P
    Adv Hematol; 2020; 2020():7636104. PubMed ID: 32231703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Surgeons Should Know About Non-Vitamin K Oral Anticoagulants: A Review.
    Verma A; Ha ACT; Rutka JT; Verma S
    JAMA Surg; 2018 Jun; 153(6):577-585. PubMed ID: 29710221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery.
    Milling TJ; Ziebell CM
    Trends Cardiovasc Med; 2020 Feb; 30(2):86-90. PubMed ID: 30952383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
    Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can we reverse bleeding in patients on direct oral anticoagulants?
    Crowther M; Cuker A
    Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants.
    Eikelboom JW; Kozek-Langenecker S; Exadaktylos A; Batorova A; Boda Z; Christory F; Gornik I; Kėkštas G; Kher A; Komadina R; Koval O; Mitic G; Novikova T; Pazvanska E; Ratobilska S; Sütt J; Winder A; Zateyshchikov D
    Br J Anaesth; 2018 Apr; 120(4):645-656. PubMed ID: 29576106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of Novel Anticoagulants in Emergent Surgery and Trauma: A Comprehensive Review and Proposed Management Algorithm.
    Palaiodimos L; Miles J; Kokkinidis DG; Barkolias C; Jonnalagadda AK; Papaconstantinou D; Frountzas M; Misiakos EP; Schizas D
    Curr Pharm Des; 2018; 24(38):4540-4553. PubMed ID: 30585542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.
    Hirschl M; Kundi M
    Vasa; 2014 Sep; 43(5):353-64. PubMed ID: 25147012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral Anticoagulants: Management of Elective and Emergency Surgery].
    Nowak H; Unterberg M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Jul; 53(7-08):543-550. PubMed ID: 30036900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative management of patients on new oral anticoagulants.
    Lai A; Davidson N; Galloway SW; Thachil J
    Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.
    Lee SR; Choi EK; Kwon S; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH
    Stroke; 2019 Aug; 50(8):2245-2249. PubMed ID: 31208303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.
    Enriquez A; Lip GY; Baranchuk A
    Europace; 2016 Jul; 18(7):955-64. PubMed ID: 25816811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.